Published in Neuroreport on February 08, 2005
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol (2008) 2.83
Neurotrophic factors and structural plasticity in addiction. Neuropharmacology (2008) 1.99
Brain-derived neurotrophic factor and cocaine addiction. Brain Res (2009) 1.76
Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci (2010) 1.47
Molecular mechanisms of psychostimulant-induced structural plasticity. Pharmacopsychiatry (2009) 1.25
Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity. Psychopharmacology (Berl) (2011) 1.18
Molecular and genetic substrates linking stress and addiction. Brain Res (2009) 1.11
Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09
Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem (2008) 1.07
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04
Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects. Eur J Neurosci (2006) 1.04
Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem (2011) 1.02
TrkB signaling is required for behavioral sensitization and conditioned place preference induced by a single injection of cocaine. Neuropharmacology (2010) 1.01
Brain-derived neurotrophic factor signaling modulates cocaine induction of reward-associated ultrasonic vocalization in rats. J Pharmacol Exp Ther (2009) 0.99
Brain-derived neurotrophic factor rapidly increases AMPA receptor surface expression in rat nucleus accumbens. Eur J Neurosci (2011) 0.98
Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance. J Neurosci (2013) 0.97
Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity. J Neurosci (2015) 0.96
Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice. Genes Brain Behav (2008) 0.94
MicroRNAs in addiction: adaptation's middlemen? Mol Psychiatry (2011) 0.91
Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain. J Neurosci (2011) 0.90
Multiple faces of BDNF in cocaine addiction. Behav Brain Res (2014) 0.90
BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict Biol (2012) 0.89
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine. Front Pharmacol (2014) 0.86
Cocaine self-administration leads to alterations in temporal responses to cocaine challenge in limbic and motor circuitry. Eur J Neurosci (2011) 0.86
BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci (2013) 0.86
Epigenetics and psychostimulant addiction. Cold Spring Harb Perspect Med (2013) 0.86
Cocaine induces cell death and activates the transcription nuclear factor kappa-B in PC12 cells. Mol Brain (2009) 0.86
Sensitized activation of Fos and brain-derived neurotrophic factor in the medial prefrontal cortex and ventral tegmental area accompanies behavioral sensitization to amphetamine. Neuropharmacology (2011) 0.86
Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood. Front Synaptic Neurosci (2014) 0.86
Intermittent social defeat stress enhances mesocorticolimbic ΔFosB/BDNF co-expression and persistently activates corticotegmental neurons: implication for vulnerability to psychostimulants. Neuroscience (2012) 0.85
FosB null mutant mice show enhanced methamphetamine neurotoxicity: potential involvement of FosB in intracellular feedback signaling and astroglial function. Neuropsychopharmacology (2009) 0.85
Methamphetamine differentially affects BDNF and cell death factors in anatomically defined regions of the hippocampus. Neuroscience (2014) 0.84
Regulation of BDNF expression by cocaine. Yale J Biol Med (2012) 0.84
Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression. Neuroreport (2009) 0.84
Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development. Front Pharmacol (2014) 0.84
Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regions. Neuroscience (2011) 0.84
Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction. Eur Neuropsychopharmacol (2014) 0.83
An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction. Front Pharmacol (2012) 0.82
Advances in genetic studies of substance abuse in China. Shanghai Arch Psychiatry (2013) 0.81
Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo. Cell Mol Neurobiol (2009) 0.81
Cocaine conditioned behavior: a cocaine memory trace or an anti-habituation effect. Pharmacol Biochem Behav (2008) 0.80
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone. Neuropsychopharmacology (2014) 0.80
Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors. Psychopharmacology (Berl) (2010) 0.80
Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors. Neuroscience (2010) 0.80
Lack of abuse potential in a highly selective dopamine D3 agonist, PF-592,379, in drug self-administration and drug discrimination in rats. Behav Pharmacol (2012) 0.79
The Role of BDNF/TrkB Signaling in Acute Amphetamine-Induced Locomotor Activity and Opioid Peptide Gene Expression in the Rat Dorsal Striatum. Front Syst Neurosci (2011) 0.79
Systemic Delivery of a Brain-Penetrant TrkB Antagonist Reduces Cocaine Self-Administration and Normalizes TrkB Signaling in the Nucleus Accumbens and Prefrontal Cortex. J Neurosci (2016) 0.77
Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users. Neuropsychopharmacology (2016) 0.77
CNS genes implicated in relapse. Subst Abuse (2008) 0.77
The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake. Psychopharmacology (Berl) (2014) 0.77
An intrastriatal brain-derived neurotrophic factor infusion restores striatal gene expression in Bdnf heterozygous mice. Brain Struct Funct (2010) 0.77
Prefrontal cortical BDNF: A regulatory key in cocaine- and food-reinforced behaviors. Neurobiol Dis (2016) 0.77
Developing biomarkers for methamphetamine addiction. Curr Neuropharmacol (2011) 0.76
Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse. Neuroscience (2014) 0.76
Dopamine-sensitive signaling mediators modulate psychostimulant-induced ultrasonic vocalization behavior in rats. Behav Brain Res (2015) 0.76
Reward Circuitry in Addiction. Neurotherapeutics (2017) 0.76
Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain Management. Curr Neuropharmacol (2011) 0.75
Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition. Br J Pharmacol (2015) 0.75
[Future medications for tobacco and cannabis dependence]. Bull Acad Natl Med (2008) 0.75
Intravenous Prenatal Nicotine Exposure Alters METH-Induced Hyperactivity, Conditioned Hyperactivity, and BDNF in Adult Rat Offspring. Dev Neurosci (2016) 0.75
Cocaine conditioning: reversal by autoreceptor dose levels of 8-OHDPAT. Pharmacol Biochem Behav (2008) 0.75
MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metab Brain Dis (2017) 0.75
Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. J Infect Dis (2013) 1.79
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat Med (2003) 1.73
Wenckebach's periods or alternating Wenckebach's periods during 4:1 atrioventricular block? J Electrocardiol (2005) 1.71
Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. Mol Biol Cell (2003) 1.47
The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology (2005) 1.43
Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. Eur J Neurosci (2009) 1.21
A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci U S A (2006) 1.20
Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology (2005) 1.18
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism Relat Disord (2005) 1.13
Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci (2002) 1.12
Glyceraldehyde-3-phosphate dehydrogenase is a GABAA receptor kinase linking glycolysis to neuronal inhibition. J Neurosci (2004) 1.07
Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse (2003) 1.03
GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling. Mol Biol Cell (2004) 1.03
Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Int J Neuropsychopharmacol (2007) 1.01
N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands. J Med Chem (2003) 1.01
E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells. Pigment Cell Melanoma Res (2013) 0.95
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol Pharmacol (2008) 0.92
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid. J Neurochem (2008) 0.91
Subapical localization of the dopamine D3 receptor in proximal tubules of the rat kidney. J Histochem Cytochem (2004) 0.90
CLIC6, a member of the intracellular chloride channel family, interacts with dopamine D(2)-like receptors. Brain Res Mol Brain Res (2003) 0.90
Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Sleep (2010) 0.89
Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci (2004) 0.89
Dopamine D3 receptor ligands for the treatment of tobacco dependence. Expert Opin Investig Drugs (2007) 0.89
Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. Eur J Pharmacol (2003) 0.89
Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands. Chembiochem (2004) 0.88
The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Neuropharmacology (2003) 0.87
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys. J Pharmacol Exp Ther (2004) 0.87
Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) (2010) 0.87
Direct and indirect interactions of the dopamine D₃ receptor with glutamate pathways: implications for the treatment of schizophrenia. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.86
Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. Int Rev Neurobiol (2004) 0.83
Immunohistological localization of the myelinating cell-specific receptor LP(A1). Glia (2002) 0.82
Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice. Neuroreport (2004) 0.81
A dopamine D3 receptor partial agonist blocks the expression of conditioned activity. Neuroreport (2002) 0.81
Cellular BRET assay suggests a conformational rearrangement of preformed TrkB/Shc complexes following BDNF-dependent activation. Cell Signal (2009) 0.81
Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders. Neurotox Res (2003) 0.79
N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands. Arch Pharm (Weinheim) (2007) 0.78
Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. Psychopharmacology (Berl) (2009) 0.77
Illicit drug use in seven Latin American countries: critical perspectives of families and familiars. Rev Lat Am Enfermagem (2009) 0.76
Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia. PLoS One (2013) 0.76
Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference. Psychopharmacology (Berl) (2004) 0.76
2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells. Horm Cancer (2010) 0.76
Harms C1-C2 instrumentation technique: anatomo-surgical guide. Spine (Phila Pa 1976) (2011) 0.76
New therapeutic targets to develop molecules active in drug-resistant epilepsies. Epilepsia (2010) 0.75
Muscle magnetic resonance imaging and histopathology in ACTA1-related congenital nemaline myopathy. Muscle Nerve (2014) 0.75